Experts, as part of the University of York's XR Stories project, have proposed a new sound strategy to developing virtual reality (VR) environments, based on how people receive images and sounds from the real world, ultimately ...
Aug 3, 2022
0
38
Picture this scenario: You and a friend are walking around your neighborhood when you stop at a crosswalk. As you wait, the noises of the world and your internal thoughts all vie for your attention. Suddenly, you see a motorist ...
Aug 24, 2023
0
2
Many studies claiming that artificial intelligence is as good as (or better than) human experts at interpreting medical images are of poor quality and are arguably exaggerated, posing a risk for the safety of 'millions of ...
Mar 25, 2020
0
68
An experiment carried out across ten workplace cafeterias found no significant change in the overall number of calories purchased when food and drink labels showed the amount of physical activity required to burn off their ...
Nov 8, 2022
0
39
Researchers at the Quadram Institute on the Norwich Research Park have shown how the development of antibiotic resistance by bacteria can have 'side-effects' for them including affecting their ability to cause disease.
Jan 11, 2021
0
8
In baseball, a pitch can take as little as 400 milliseconds to reach the plate. With a typical reaction time of 200 milliseconds and a swing of about 150 milliseconds, a batter must decide whether to swing and how to swing ...
Sep 14, 2021
1
73
Long before they enter a classroom, people learn to identify commonplace objects like a "dog" and a "chair" just by encountering them in everyday life, with no intent to learn about what they are.
May 27, 2022
1
34
For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and may benefit overall survival, according to a new ...
Nov 21, 2023
0
37
The introduction of lung cancer screening in the US in December 2013 is associated with more patients being diagnosed at an earlier stage and improved survival, finds a study published by The BMJ today.
Mar 30, 2022
0
2
South Korea on Thursday received its first supply of Pfizer's antiviral COVID-19 pills to treat patients with mild or moderate symptoms.
Jan 13, 2022
0
5
